Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey.

Autor:	Elosua González A; Unidad de Aparato Digestivo, Hospital García Orcoyen, Estella, Navarra, España. Electronic address: alfonso.elosua@gmail.com., Nantes Castillejo Ó; Servicio de Aparato Digestivo, Complejo Hospitalario de Navarra, Pamplona, España; Instituto de Investigación Sanitaria de Navarra (idiSNA), Pamplona, España., Fernández-Urién Sainz I; Servicio de Aparato Digestivo, Complejo Hospitalario de Navarra, Pamplona, España., López-García A; Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, España., Murcia Pomares Ó; Unidad de Gastroenterología, Hospital General Universitario de Alicante, Alicante, España., Zabana Y; Unidad de Enfermedad Inflamatoria Intestinal, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, España; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), España.
Jazyk:	English; Spanish; Castilian
Zdroj:	Gastroenterologia y hepatologia [Gastroenterol Hepatol] 2021 Dec; Vol. 44 (10), pp. 696-703. Date of Electronic Publication: 2021 Apr 16.
DOI:	10.1016/j.gastrohep.2021.02.013
Abstrakt:	Introduction: Small bowel capsule endoscopy (SBCE) is a non-invasive diagnostic technique whose use in inflammatory bowel disease (IBD) has spread. A panenteric capsule, PillCam Crohn's (PCC), has recently been developed. We lack information on the availability and use of the CEID and PCC in our environment. Methods: We conducted an electronic and anonymous survey among the members of the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) [Spanish Working Group on Crohn's Disease and Ulcerative Colitis] and the Asociación Española de Gastroenterología (AEG) [Spanish Association of Gastroenterology], consisting of 37 multiple-choice questions. Results: One hundred and fifty members participated, the majority dedicated to IBD (69.3%). 72.8% worked at centres with an IBD unit. 79% had SBCE available at their hospital, 14% referred patients to another centre; 22% had a PCC available, 9% referred patients to another centre. 79.3% of respondents with available SBCE used it in a small percentage of patients with IBD and 15.6% in the majority. The most frequent scenarios were suspicion of Crohn's disease (76.3%), assessment of inflammatory activity (54.7%) and assessment of the extent of the disease (54.7%). More than half (59.7%) preferentially used the Patency capsule to assess intestinal patency. Almost all respondents (99.3%) considered that training resources should be implemented in this technique. Conclusions: SBCE is widely available in Spanish hospitals for the management of IBD, although its use is still limited. There is an opportunity to increase training in this technique, and consequently its use. (Copyright © 2021 Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu